Why is Infinium Pharma falling/rising?

As of 12-Sep, Infinium Pharmachem Ltd is experiencing a decline in its stock price, currently at 250.60, which reflects a decrease of 4.25 or 1.67%. The stock has underperformed its sector today by 1.96%, and it is trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 34.21% compared to the 5-day average. Over the past week, the stock has shown a slight increase of 0.24%, but it has underperformed over the past month and year-to-date, with declines of 0.65% and 16.44%, respectively. The one-year return is positive at 30.22%, but the lack of available positive or negative factors makes it difficult to pinpoint specific reasons for the recent price movement.
In the broader market context, the stock's short-term performance has lagged behind the benchmark, with the Sensex gaining 1.51% over the past week while Infinium Pharmachem Ltd only increased by 0.24%. This underperformance is further highlighted by the stock's year-to-date decline of 16.44% compared to the Sensex's gain of 6.21%. The overall market appears to be performing better than Infinium, which may contribute to investor sentiment and the stock's current downward trend.